A Single Amino Acid in Nonstructural Protein NS4B Confers Virulence to Dengue Virus in AG129 Mice through Enhancement of Viral RNA Synthesis

被引:64
作者
Grant, Dixon [1 ,2 ]
Tan, Grace K. [3 ]
Qing, Min [1 ,4 ]
Ng, Jowin K. W. [3 ]
Yip, Andy [1 ]
Zou, Gang [1 ]
Xie, Xuping [1 ,4 ]
Yuan, Zhiming [4 ]
Schreiber, Mark J. [1 ]
Schul, Wouter [1 ]
Shi, Pei-Yong [1 ]
Alonso, Sylvie [3 ]
机构
[1] Novartis Inst Trop Dis, Singapore, Singapore
[2] Duke Natl Univ Singapore, Grad Sch Med, Singapore, Singapore
[3] Natl Univ Singapore, Immunol Programme, Dept Microbiol, Singapore 117548, Singapore
[4] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Beijing 100864, Peoples R China
基金
英国医学研究理事会;
关键词
WEST-NILE-VIRUS; 3'-UNTRANSLATED REGION; VACCINE CANDIDATES; STRAIN; INHIBITION; DISEASE; TYPE-2; IDENTIFICATION; REPLICATION; INFECTION;
D O I
10.1128/JVI.00665-11
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Dengue (DEN) is a mosquito-borne viral disease that has become an increasing economic and health burden for the tropical and subtropical world. The lack of an appropriate animal model of DEN has greatly impeded the study of its pathogenesis and the development of vaccines/antivirals. We recently reported a DEN virus 2 (DENV-2) strain (D2Y98P) that lethally infects immunocompromised AG129 mice, resulting in organ damage or dysfunction and increased vascular permeability, hallmarks of severe DEN in patients (G. K. Tan et al., PLoS Negl. Trop. Dis. 4:e672, 2010). Here we report the identification of one critical virulence determinant of strain D2Y98P. By mutagenesis, we showed that a Phe-to-Leu alteration at amino acid position 52 in nonstructural protein NS4B completely abolished the pathogenicity of the D2Y98P virus, as evidenced by a lack of lethality and the absence of histological signs of disease, which correlated with reduced viral titers and intact vascular permeability. Conversely, a Leu-to-Phe alteration at position 52 of NS4B in nonvirulent DENV-2 strain TSV01 led to 80% lethality and increased viremia. The NS4B(Phe52) viruses displayed enhanced RNA synthesis in mammalian cells but not in mosquito cells. The increased viral RNA synthesis was independent of the ability of NS4B to interfere with the host type I interferon response. Overall, our results demonstrate that Phe at position 52 in NS4B confers virulence in mice on two independent DENV-2 strains through enhancement of viral RNA synthesis. In addition to providing further insights into the functional role of NS4B protein, our findings further support a direct relationship between viral loads and DEN pathogenesis in vivo, consistent with observations in DEN patients.
引用
收藏
页码:7775 / 7787
页数:13
相关论文
共 46 条
[1]  
[Anonymous], J VIROL
[2]   NS5 of Dengue Virus Mediates STAT2 Binding and Degradation [J].
Ashour, Joseph ;
Laurent-Rolle, Maudry ;
Shi, Pei-Yong ;
Garcia-Sastre, Adolfo .
JOURNAL OF VIROLOGY, 2009, 83 (11) :5408-5418
[3]   FATAL HEMORRHAGIC-DISEASE AND SHOCK ASSOCIATED WITH PRIMARY DENGUE INFECTION ON A PACIFIC ISLAND [J].
BARNES, WJS ;
ROSEN, L .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1974, 23 (03) :495-506
[4]   Selection-driven evolution of emergent dengue virus [J].
Bennett, SN ;
Holmes, EC ;
Chirivella, M ;
Rodriguez, DM ;
Beltran, M ;
Vorndam, V ;
Gubler, DJ ;
McMillan, WO .
MOLECULAR BIOLOGY AND EVOLUTION, 2003, 20 (10) :1650-1658
[5]   Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist [J].
Best, SM ;
Morris, KL ;
Shannon, JG ;
Robertson, SJ ;
Mitzel, DN ;
Park, GS ;
Boer, E ;
Wolfinbarger, JB ;
Bloom, ME .
JOURNAL OF VIROLOGY, 2005, 79 (20) :12828-12839
[6]   Mutations which enhance the replication of dengue virus type 4 and an antigenic chimeric dengue virus type 2/4 vaccine candidate in Vero cells [J].
Blaney, JE ;
Manipon, GG ;
Firestone, CY ;
Johnson, DH ;
Hanson, CT ;
Murphy, BR ;
Whitehead, SS .
VACCINE, 2003, 21 (27-30) :4317-4327
[7]   Dengue virus type 3 vaccine candidates generated by introduction of deletions in the 3′ untranslated region (3′-UTR) or by exchange of the DENV-3 3′-UTR with that of DENV-4 [J].
Blaney, Joseph E., Jr. ;
Sathe, Neeraj S. ;
Goddard, Laura ;
Hanson, Christopher T. ;
Romero, Tammy A. ;
Hanley, Kathryn A. ;
Murphy, Brian R. ;
Whitehead, Stephen S. .
VACCINE, 2008, 26 (06) :817-828
[8]   Genetic determinants responsible for acquisition of dengue type 2 virus mouse neurovirulence [J].
Bray, M ;
Men, R ;
Tokimatsu, I ;
Lai, CJ .
JOURNAL OF VIROLOGY, 1998, 72 (02) :1647-1651
[9]   A PROSPECTIVE-STUDY OF DENGUE INFECTIONS IN BANGKOK [J].
BURKE, DS ;
NISALAK, A ;
JOHNSON, DE ;
SCOTT, RM .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1988, 38 (01) :172-180
[10]   Dengue Vaccine Candidates in Development [J].
Durbin, Anna P. ;
Whitehead, Stephen S. .
DENGUE VIRUS, 2010, 338 :129-143